| Name | 4-N-(3-bromophenyl)-6-N-but-1-en-2-ylquinazoline-4,6-diamine |
|---|
| Description | PD 174265 is a potent, cell-permeable, reversible, and selective inhibitor of EGFR with an IC50 of 450 pM[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C17H15BrN4O |
|---|---|
| Molecular Weight | 371.23100 |
| Exact Mass | 370.04300 |
| PSA | 66.91000 |
| LogP | 4.63040 |
|
~47%
216163-53-0 |
| Literature: Warner-Lambert Company Patent: US6344459 B1, 2002 ; Location in patent: Page column 61-62 ; US 6344459 B1 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |